Sinovac Biotech (SVA) Reports Q4 EPS of $0.01

Sinovac Biotech (NASDAQ: SVA) reported Q4 EPS of $0.01, versus $0.02 reported last year. Revenue for the quarter came in at $22.95 million, versus $20.3 million reported last year.

For earnings history and earnings-related data on Sinovac Biotech (SVA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15